Pfizer Faces Continued Stock Decline Amid Broader Market Weakness and Mixed Momentum

Pfizer has experienced a notable decline today, with shares falling by 3.22% as of August 1, 2025. This drop marks a continuation of a downward trend, as the stock has now lost 4.18% over the past three days. The stock's performance today underperformed the broader Pharmaceuticals & Biotechnology sector, which itself has seen a decrease of 2.84%.
Intraday, Pfizer reached a low of Rs 5060. In terms of moving averages, the stock is currently above its 100-day and 200-day averages but below its 5-day, 20-day, and 50-day averages, indicating mixed short-term momentum.

In the context of the overall market, the Sensex has also been on a downward trajectory, falling by 0.4% to 80,860.29 points after a negative opening. Over the past month, Pfizer's performance has been particularly weak, down 10.79%, compared to the Sensex's decline of 3.39%. Despite these challenges, Pfizer maintains a high dividend yield of 3.83% at its current price, reflecting its commitment to returning value to shareholders.